l-Arterenol d-bitartrate belongs to the family of organic compounds known as catecholamines, which people in healthcare and research circles often recognize as norepinephrine bitartrate. This compound forms part of a group that plays a role in both medicinal applications and chemical manufacturing. Scientists isolate and synthesize it from raw materials that provide a base for focused work in pharmacological contexts or synthetic chemistry labs. Knowledge of its source and method of preparation is essential, since the quality of raw materials fuels consistency in research and industrial processes.
In its pure state, l-Arterenol d-bitartrate appears as a crystalline solid. Many labs have handled samples that fall somewhere between white and faint yellow, reflecting its sensitivity to oxidation, air exposure, and moisture. Density lies close to 1.7 g/cm3, providing a relatively compact crystal that dissolves readily in water, where it forms a clear and stable solution. Touching or smelling this chemical does not yield much; no significant odor distinguishes it. The response to environmental factors remains a consideration, since even exposure to light or air tends to decompose the chemical over time. This underscores the importance of proper storage conditions, including tight containers and cool, dark spaces, especially where sensitive experiments or bulk storage occur.
The molecular formula C8H11NO3·C4H6O6 captures the structure of l-Arterenol d-bitartrate, which combines a catecholamine backbone with a d-bitartrate counterion. This pairing adds stability and improves solubility in aqueous solutions, factors that make it popular as a pharmaceutical intermediate and as a chemical reference standard. Its structure allows researchers to investigate pathways of neurotransmission or stimulate heart contraction in clinical settings. A practical understanding of its formula helps chemists anticipate reactions or prepare precise concentrations for dosing and standardization.
Manufacturers and suppliers normally refine l-Arterenol d-bitartrate to a purity exceeding 98%, as impurities could affect both biological research and drug formulation. Packaging reflects the need for stability; bottles or vials typically come lined or made from materials resistant to moisture intrusion. Typical sizes range from small laboratory quantities in grams up to multi-kilogram containers for production-scale needs. Labels cite the HS Code 29393000, identifying it for customs and trade compliance as a chemical compound used in pharmaceutical synthesis and laboratory analysis. The exact specification sheet guides anybody responsible for handling or importing this compound, ensuring traceability and safe transfer through regulated channels.
Depending on the process, l-Arterenol d-bitartrate may present as a free-flowing powder, larger crystalline flakes, or compacted pearls. Labs see powder and flakes most often since these forms dissolve efficiently, making solution preparation fast and accurate. Bulk manufacturers sometimes distribute it as small granules or pressed pieces, which allows for easier weighing and minimizes the tendency for dust and contamination. Whether used as a raw material or dispensed for clinical use, each form calls for careful handling to prevent loss and ensure sample purity, especially since this substance absorbs water rapidly and changes appearance if left exposed. Choices about form depend on the intended application, available storage, and the need for rapid reconstitution into solution.
l-Arterenol d-bitartrate poses several chemical hazards that demand respect and careful procedure. Contact with heat, direct sunlight, or oxidizing materials risks decomposition, sometimes releasing irritating fumes. Skin and eye exposure can lead to local irritation, and accidental inhalation of dust or particles presents toxicological risks. With use in medical or research environments, those involved employ gloves, lab coats, and, frequently, protective eyewear. Many labs install dedicated fume hoods or extraction systems where large quantities enter solution. With safety data sheets as a reference, procedures require immediate cleanup of spills, proper containment, and ready access to eyewash stations and emergency showers. Disposal follows hazardous chemical regulations, with most facilities coordinating with certified chemical waste handlers rather than releasing such compounds into the regular waste stream. Adhering to these steps guards not only researchers and handlers but also the broader environment, preventing accidental release or exposure.
Uses for l-Arterenol d-bitartrate extend from the clinical treatment of cardiovascular conditions, acting as a direct stimulant for raising blood pressure, to laboratory investigation of sympathetic nervous system function. In my experience working alongside analytical chemists, its presence in precise concentrations allows for calibration of assays and instrumentation, providing a reliable benchmark that keeps results trustworthy. Pharmaceutical companies lean heavily on quality batches for formulation and testing, as off-specification material risks disrupting workflows or patient safety. The compound’s dual role—serving both investigation and intervention—makes its quality of life impact profound, even though many outside the biomedical field may not recognize the name.
Maintaining product integrity throughout storage and use remains a challenge. Laboratories often train personnel to recognize early signs of decomposition or contamination and emphasize rapid transfer from bottle to solution with minimal open-air time. Investments in better desiccation and temperature controls inside storage rooms reduce risk. For large-scale manufacturers, streamlining batch testing and establishing robust supplier qualification processes has become the norm. Audits and certifications by recognized authorities add trust, minimizing the chance of substandard product entering research or clinical workflows. For those handling import, knowing the HS Code and providing the right documentation at customs speeds up clearance and keeps delays from disrupting critical supply chains. Where risks of hazardous exposure emerge, robust training and easily accessible safety materials reduce accidents, and experienced managers regularly update policies as regulatory or scientific guidance evolves. Combining vigilant supply management with careful onsite protocols goes a long way toward supporting consistent, safe outcomes in any setting that uses l-Arterenol d-bitartrate.
Providing high-quality chemical products and logistics solutions for global trade partners.
